Meghan Scanlon - SVP,Pres,Urology Pelvic Health at BOSTON SCIENTIFIC CORP

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP,Pres,Urology Pelvic Health
Issuer Symbol
BSX on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Meghan Scanlon since 10 Mar 2025

Holdings reported by Meghan Scanlon for BOSTON SCIENTIFIC CORP

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 24,461 $1,467,660 $60.00 01 May 2022 Direct
Deferred Stock Units 2,062 $111,472 $54.06 01 May 2022 Direct Common Stock

Transactions reported by Meghan Scanlon for BOSTON SCIENTIFIC CORP

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.